XML 37 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based Payment Arrangements (Tables)
9 Months Ended
Sep. 25, 2021
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
    
Thirty Nine Weeks Ended
    
Thirteen Weeks Ended
 
    
September 25,
    
September 26,
    
September 25,
    
September 26,
 
    
2021
    
2020
    
2021
    
2020
 
Total cost of the Plans during the period
   $ 18,717      $ 2,691      $ 7,824      $ 1,490  
Amount of related income tax benefit recognized during the period
     (5,636      (1,618      (1,919      (483
    
 
 
    
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 13,081      $ 1,073      $ 5,905      $ 1,007  
    
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
    
Number of
    
Weighted Average
Grant Date
 
    
RSUs
    
Fair Value
 
Outstanding at December 26, 2020
     183,213      $ 93.44  
Granted
     46,103      $ 128.78  
Shares earned in excess of target
(1)
     7,132      $ 31.97  
Vested shares
     (24,600    $ 59.85  
Forfeited
     (2,688    $ 107.76  
    
 
 
          
Outstanding at September 25, 2021
     209,160      $ 102.90  
    
 
 
          
 
(1)
Represents shares earned in excess of target under the May 1, 2015 RSU award as total shareholder return exceeded the target under the award.
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans:
 
 
  
Number of
Options
 
  
Weighted 
Average
Exercise Price
 
per
Share
 
  
Weighted 
Average
Remaining
Contractual
Term 
(years)
 
  
Aggregate
 Intrinsic
Value (000s)
 
Options outstanding at December 26, 2020
  
 
17,650
 
  
$
54.16
 
  
 
 
 
  
 
 
 
Exercised
  
 
(6,480
  
$
52.68
 
  
 
 
 
  
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Options outstanding at September 25, 2021
  
 
11,170
 
  
$
55.02
 
  
 
1.0
 
  
$
1,224
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Options exercisable at September 25, 2021
  
 
11,170
 
  
$
55.02
 
  
 
1.0
 
  
$
1,224
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
    
Number of Shares

and Deferred Stock
Units
    
Weighted Average

Grant Date

Fair Value
 
Non-vested
at December 26, 2020
     60,440      $ 103.65  
Granted
     26,351      $ 150.20  
Vested
     (29,055    $ 104.35  
Forfeited
     (1,300    $ 97.81  
    
 
 
          
Non-vested
at September 25, 2021
     56,436      $ 125.16